{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2016", "item": "https://www.patentleaderboard.com/2016/"}, {"@type": "ListItem", "position": 3, "name": "Sanofi", "item": "https://www.patentleaderboard.com/2016/company/sanofi"}, {"@type": "ListItem", "position": 4, "name": "Andreas Evers", "item": "https://www.patentleaderboard.com/2016/inventor/fl:an_ln:evers-6"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
AE

Andreas Evers — 4 Patents in 2016

SASanofi: 4 patents #6 of 215Top 3%
Frankfurt am Main, DE: #14 of 201 inventorsTop 7%
Overall (2016): #47,617 of 481,213Top 10%
4 Patents 2016

Issued Patents 2016

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
9365632 Exendin-4 derivatives as dual GLP1/glucagon agonists Torsten Haack, Michael Wagner, Bernd Henkel, Siegfried Stengelin, Martin Bossart 2016-06-14 $5,305,000
9346757 Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation Marc Nazare, Detlef Kozian, Werngard Czechtizky 2016-05-24 $4,497,000
9346762 Pyrazole derivatives and their use as LPAR5 antagonists Marc Nazare, Detlef Kozian, Werngard Czechtizky 2016-05-24 $4,497,000
9309207 Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa Christopher Kallus, Mark Broenstrup, Anja Globisch, Herman Schreuder, Michael Wagner 2016-04-12 $28,790,000